Skip to Main Content
A service of the U.S. National Institutes of Health
Example: "Heart attack" AND "Los Angeles"
Search for studies:
Advanced Search
Help
Studies by Topic
Glossary
Find Studies
Basic Search
Advanced Search
See Studies by Topic
See Studies on a Map
How to Search
How to Use Search Results
How to Find Results of Studies
How to Read a Study Record
About Clinical Studies
Learn About Clinical Studies
Other Sites About Clinical Studies
Glossary of Common Site Terms
Submit Studies
Why Should I Register and Submit Results?
FDAAA 801 Requirements
How to Apply for an Account
How to Register Your Study
How to Edit Your Study Record
How to Submit Your Results
Frequently Asked Questions
Support Materials
Training Materials
Resources
Selected Publications
Clinical Alerts and Advisories
RSS Feeds
Trends, Charts, and Maps
Downloading Content for Analysis
About This Site
ClinicalTrials.gov Background
About the Results Database
History, Policies, and Laws
Media/Press Resources
Linking to This Site
Terms and Conditions
Disclaimer
Text Size
Make bigger
Make smaller
Reset
close
Home
Find Studies
Search Results
28 studies found for
: " October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Modify this search
|
How to Use Search Results
List
By Topic
On a Map
Search Details
Show Display Options
Subscribe to RSS
Create an RSS feed from your search for:
" October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See
RSS Feeds
Choose a feed type:
Show studies that were
first received
in the last 14 days
Show studies that were
added
or
modified
in the last 14 days
Cancel
Download
Download the search results for:
" October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (28 records)
Need help? See
Downloading Content for Analysis
Number of Studies:
Top 10 Studies
20 Shown Studies
28 Found Studies
Download Content:
Download All Study Fields as XML
Download All Study and Results Fields as XML
Download Selected Fields:
Select fields:
2 Shown Fields
21 Available Fields
Select field format:
Plain text
Tab-separated values
Comma-separated Values
XML
Zip file readers with free trial periods:
WinZip
or
PKZip
Cancel
Display Options
Study Details
Condition
Intervention
Study Type
Phase
Sponsor/Collaborators
Funder Type
Study Design
Outcome Measures
Participant Details
Number Enrolled
Gender
Age Group
Identifiers
NCT Number
Other IDs
Title Acronym
Dates
Study Start
Primary Completion
Study Completion
First Received
Last Updated
Last Verified
Results First Received
Cancel
Include only
open studies
Exclude studies with
unknown status
Rank
Status
Study
1
Recruiting
Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents
Conditions:
Acquired Immunodeficiency Syndrome; HIV Infections
Intervention:
Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df
2
Recruiting
Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Conditions:
Acquired Immunodeficiency Syndrome; HIV Infections
Interventions:
Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df; Drug: ritonavir + atazanavir + emtricitabine/tenofovir df
3
Recruiting
A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions:
HIV Positive; Ageing
Intervention:
4
Not yet recruiting
A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
Condition:
HCV and HIV Seropositive Coinfection
Interventions:
Drug: boceprevir; Drug: Ribavirin; Drug: Peginterferon alfa-2a; Drug: Peginterferon alfa-2b
5
Not yet recruiting
Comparison of Two IUDs Among Cape Town HIV-positive Women: A Randomized Controlled Trial Assessing Safety of Registered Products in South Africa
Condition:
HIV
Interventions:
Device: Mirena levonorgestrel IUD; Device: Copper T-380a IUD
6
Recruiting
Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women
Condition:
Cervical Dysplasia in HIV Positive Women
Interventions:
Procedure: Cryotherapy; Procedure: LEEP
7
Recruiting
Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition:
HIV Infections
Interventions:
Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU); Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU); Biological: Ad35-GRIN (0.5mL)
8
Recruiting
First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition:
HIV
Interventions:
Drug: Maraviroc; Drug: TVD 300/200 QD
9
Active, not recruiting
Comparison of HIV Testing Algorithms
Condition:
HIV Infection
Intervention:
Other: application of a confirmation test
10
Active, not recruiting
Re-boosting of HIV-1 Infected Subjects With Vacc-4x
Condition:
HIV-1 Infection
Intervention:
Biological: Vacc-4x
11
Not yet recruiting
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition:
Human Immunodeficiency Virus
Interventions:
Device: Intervention Arm (computer-based CARE+ Corrections tool); Other: Educational video on opiate overdose prevention
12
Not yet recruiting
A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Condition:
Human Immunodeficiency Virus-Type 1
Intervention:
Drug: No intervention
13
Not yet recruiting
A Study to Compare Efficacy in Terms of Plasma Human Immunodeficiency Virus-Type 1 (HIV-1) Ribonucleic Acid (RNA) Between 2 Fixed Dose Combinations After a Switch in Fully Suppressed Patients
Condition:
Human Immunodeficiency Virus-type 1 Infection
Interventions:
Drug: Rilpivirine; Drug: Efavirenz; Drug: Tenofovir disoproxil fumarate; Drug: Emtricitabine
14
Recruiting
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
Condition:
HIV-1 Infection
Interventions:
Drug: FZD; Drug: 3TC; Drug: EFV; Drug: AZT
15
Active, not recruiting
A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With HIV-1
Condition:
HIV Infection
Interventions:
Drug: Raltegravir Film-coated Tablet; Drug: Raltegravir Chewable Tablet
16
Recruiting
Network Supported Engagement In HIV Care
Conditions:
HIV; Patient Acceptance of Health Care
Intervention:
Other: Supportive Care
17
Not yet recruiting
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Conditions:
Cocaine-Related Disorders; HIV; Heroin Dependence
Interventions:
Drug: Methadone; Drug: Buprenorphine; Behavioral: Employment-based drug abstinence reinforcement
18
Recruiting
Antimalarial Pharmacology in Children and Pregnant Women in Uganda
Conditions:
Malaria; HIV
Intervention:
19
Recruiting
A Pilot Trial of an Individualized Web-Based Condom Use Intervention
Condition:
HIV
Intervention:
Behavioral: Condom-HIM
20
Recruiting
Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
Condition:
HIV
Intervention:
Drug: maraviroc
To Top
Previous Page
Studies Shown (1-20)
Next Page (21-28)
†
Indicates status has not been verified in more than two years
To Top
Copyright
Privacy
Accessibility
Viewers & Players
Freedom of Information Act
USA.gov
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services